190
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Splenic Infarction with Myocardial Injury in a Diabetic Patient: A Case Report

, ORCID Icon &
Pages 2929-2937 | Received 25 Jun 2023, Accepted 18 Sep 2023, Published online: 22 Sep 2023

References

  • Yen CC, Wang CK, Chen SY, et al. Risk assessment and prognostic analysis of patients with splenic infarction in emergency department: a multicenter retrospective study. Sci Rep. 2021;11(1):21423. doi:10.1038/s41598-021-00897-0
  • Tanaka Y, Matsumoto M, Yahata T, Mineki T, Oiwa K. Two cases of multiple thromboembolism with asymptomatic atrial fibrillation. Cureus. 2022;14(1):e21645. doi:10.7759/cureus.21645
  • Piya MK, McTernan PG, Kumar S. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J Endocrinol. 2013;216(1):T1–T15. doi:10.1530/JOE-12-0498
  • Weber E, Grangeon F, Reynaud Q, et al. Acute renal and splenic infarctions: a review. QJM. 2020;113(3):186–193. doi:10.1093/qjmed/hcz252
  • Hakoshima M, Kitakaze K, Adachi H, Katsuyama H, Yanai H. Clinical, hematological, biochemical and radiological characteristics for patients with splenic infarction: case series with literature review. J Clin Med Res. 2023;15(1):38–50. doi:10.14740/jocmr4836
  • Tóth PP, Reuter RK, MacDonald J. Spontaneous splenic infarction secondary to diabetes-induced microvascular disease. Arch Fam Med. 2000;9(2):195–197. doi:10.1001/archfami.9.2.195
  • Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018;16(2):231–241. doi:10.1111/jth.13911
  • Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(4):709–725. doi:10.1161/ATVBAHA.117.309846
  • Cox M, Li Z, Desai V, et al. Acute nontraumatic splenic infarctions at a tertiary-care center: causes and predisposing factors in 123 patients. Emerg Radiol. 2016;23(2):155–160. doi:10.1007/s10140-016-1376-3
  • Antopolsky M, Hiller N, Salameh S, Goldshtein B, Stalnikowicz R. Splenic infarction: 10 years of experience. Am J Emerg Med. 2009;27(3):262–265. doi:10.1016/j.ajem.2008.02.014
  • Childers J, Do TVC, Smith F, Vangara A, Ganti SS, Akella R. Incidental and asymptomatic splenic infarction and infrarenal thrombus in a COVID-19 patient. Cureus. 2022;14(7):e26555. doi:10.7759/cureus.26555
  • Wand O, Tayer-Shifman OE, Khoury S, Hershko AY. A practical approach to infarction of the spleen as a rare manifestation of multiple common diseases. Ann Med. 2018;50(6):494–500. doi:10.1080/07853890.2018.1492148
  • Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug. EuroIntervention. 2016;11(10):1170–1179. doi:10.4244/EIJY15M01_06
  • Yihan L, Guanqi F, Tong H, Junye G, Zhong J, Chen T. Case report: acute renal and splenic infarctions secondary to atrial fibrillation. Front Cardiovasc Med. 2022;9:879322. doi:10.3389/fcvm.2022.879322
  • Antopolsky M, Simanovsky N, Stalnikowicz R, Salameh S, Hiller N. Renal infarction in the ED: 10-year experience and review of the literature. Am J Emerg Med. 2012;30(7):1055–1060. doi:10.1016/j.ajem.2011.06.041
  • Schattner A, Adi M, Kitroser E, Klepfish A. Acute splenic infarction at an academic general hospital over 10 years: presentation, etiology, and outcome. Medicine. 2015;94(36):e1363. doi:10.1097/MD.0000000000001363
  • Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol. 2007;27(4):705–713. doi:10.1161/01.ATV.0000261709.34878.20
  • Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. doi:10.3390/ijms21051835
  • Kitagawa I, Ono R, Tobe S, Nagatsuka M. Cardiobacterium hominis endocarditis associated with cerebral, renal, and splenic infarctions: a case report and review of the literature. IDCases. 2023;31:e01655. doi:10.1016/j.idcr.2022.e01655
  • Kaier TE, Alaour B, Marber M. Cardiac troponin and defining myocardial infarction. Cardiovasc Res. 2021;117(10):2203–2215. doi:10.1093/cvr/cvaa331
  • van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJ. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur Heart J. 2011;32(5):611–617. doi:10.1093/eurheartj/ehq491
  • Huang Y, Liu Y, Ma Y, et al. Associations of visceral adipose tissue, circulating protein biomarkers, and risk of cardiovascular diseases: a Mendelian randomization analysis. Front Cell Dev Biol. 2022;10:840866. doi:10.3389/fcell.2022.840866
  • Providência R, Paiva L, Barra S, Faustino A. Troponin rise in patients with atrial fibrillation: a marker of adverse prognosis and increased thromboembolic risk. Int J Cardiol. 2013;168(5):4889. doi:10.1016/j.ijcard.2013.07.026
  • Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48(5):1017–1021. doi:10.1007/s00125-005-1715-5
  • Shao S, Zhang X, Xu Q, Pan R, Chen Y. Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities. Pharmacol Ther. 2022;239:108270. doi:10.1016/j.pharmthera.2022.108270
  • Szatmary P, Grammatikopoulos T, Cai W, et al. Acute pancreatitis: diagnosis and treatment. Drugs. 2022;82(12):1251–1276. doi:10.1007/s40265-022-01766-4